BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38879016)

  • 1. Fatty acid desaturase insertion-deletion polymorphism rs66698963 predicts colorectal polyp prevention by the n-3 fatty acid eicosapentaenoic acid: A secondary analysis of the seAFOod polyp prevention trial.
    Sun G; Li YN; Davies JR; Block RC; Kothapalli KSD; Brenna JT; Hull MA
    Am J Clin Nutr; 2024 Jun; ():. PubMed ID: 38879016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A regulatory insertion-deletion polymorphism in the FADS gene cluster influences PUFA and lipid profiles among Chinese adults: a population-based study.
    Li P; Zhao J; Kothapalli KSD; Li X; Li H; Han Y; Mi S; Zhao W; Li Q; Zhang H; Song Y; Brenna JT; Gao Y
    Am J Clin Nutr; 2018 Jun; 107(6):867-875. PubMed ID: 29746616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype, eicosapentaenoic acid (EPA) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial.
    Sun G; Davies JR; Mell T; Harland M; Saleh RMH; Race AD; Loadman PM; Williams EA; Minihane AM; Hull MA
    Prostaglandins Leukot Essent Fatty Acids; 2024 Feb; 201():102623. PubMed ID: 38823349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use.
    Downing A; Fenton H; Nickerson C; Loadman PM; Williams EA; Rees CJ; Brown LC; Morris EJA; Hull MA
    Aliment Pharmacol Ther; 2023 Sep; 58(6):562-572. PubMed ID: 37518954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
    Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
    Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E
    Sun G; Fuller H; Fenton H; Race AD; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
    Int J Cancer; 2024 Mar; 154(5):873-885. PubMed ID: 37855394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
    Fuller H; Race AD; Fenton H; Burke L; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102570. PubMed ID: 37003144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acid biosynthesis pathway and genetics. implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19
    Kothapalli KSD; Park HG; Brenna JT
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102183. PubMed ID: 33038834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of
    Sergeant S; Keith BA; Seeds MC; Legins JA; Young CB; Vitolins MZ; Chilton FH
    Front Nutr; 2023; 10():1111624. PubMed ID: 37215219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in erythrocyte phospholipid membrane long-chain polyunsaturated fatty acids and the prevalence of fatty acid desaturase genotype among African Americans and European Americans.
    Rifkin SB; Shrubsole MJ; Cai Q; Smalley WE; Ness RM; Swift LL; Milne G; Zheng W; Murff HJ
    Prostaglandins Leukot Essent Fatty Acids; 2021 Jan; 164():102216. PubMed ID: 33310680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte polyunsaturated fatty acid composition is associated with depression and FADS genotype in Caucasians.
    Cribb L; Murphy J; Froud A; Oliver G; Bousman CA; Ng CH; Sarris J
    Nutr Neurosci; 2018 Oct; 21(8):589-601. PubMed ID: 28552045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Supplementation With Marine ω-3 Fatty Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General Population: A Prespecified Ancillary Study of a Randomized Clinical Trial.
    Song M; Lee IM; Manson JE; Buring JE; Dushkes R; Gordon D; Walter J; Wu K; Chan AT; Ogino S; Fuchs CS; Meyerhardt JA; Giovannucci EL;
    JAMA Oncol; 2020 Jan; 6(1):108-115. PubMed ID: 31750855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Selection on a Regulatory Insertion-Deletion Polymorphism in FADS2 Influences Apparent Endogenous Synthesis of Arachidonic Acid.
    Kothapalli KS; Ye K; Gadgil MS; Carlson SE; O'Brien KO; Zhang JY; Park HG; Ojukwu K; Zou J; Hyon SS; Joshi KS; Gu Z; Keinan A; Brenna JT
    Mol Biol Evol; 2016 Jul; 33(7):1726-39. PubMed ID: 27188529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease.
    Martinelli N; Girelli D; Malerba G; Guarini P; Illig T; Trabetti E; Sandri M; Friso S; Pizzolo F; Schaeffer L; Heinrich J; Pignatti PF; Corrocher R; Olivieri O
    Am J Clin Nutr; 2008 Oct; 88(4):941-9. PubMed ID: 18842780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults.
    Merino DM; Johnston H; Clarke S; Roke K; Nielsen D; Badawi A; El-Sohemy A; Ma DW; Mutch DM
    Mol Genet Metab; 2011 Jun; 103(2):171-8. PubMed ID: 21414826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and child fatty acid desaturase genotype as determinants of cord blood long-chain PUFA (LCPUFA) concentrations in the Seychelles Child Development Study.
    Conway MC; McSorley EM; Mulhern MS; Spence T; Weslowska M; Strain JJ; van Wijngaarden E; Davidson PW; Myers GJ; Wahlberg KE; Shamlaye CF; Cobice DF; Hyland BW; Pineda D; Broberg K; Yeates AJ
    Br J Nutr; 2021 Dec; 126(11):1687-1697. PubMed ID: 33526157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.